CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • September 17th, 2013 • Cubist Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 17th, 2013 Company Industry JurisdictionTHIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of September 11, 2013 (this “Agreement”), is entered into by and between Cubist Pharmaceuticals, Inc., a Delaware corporation (“Parent”), and Broadridge Corporate Issuer Solutions, Inc., a Pennsylvania corporation, as Rights Agent.
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • August 1st, 2013 • Trius Therapeutics Inc • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 1st, 2013 Company Industry JurisdictionTHIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of [—], 2013 (this “Agreement”), is entered into by and between Cubist Pharmaceuticals, Inc., a Delaware corporation (“Parent”), and Broadridge Corporate Issuer Solutions, Inc., a Pennsylvania corporation, as Rights Agent.
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • August 1st, 2013 • Cubist Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 1st, 2013 Company Industry JurisdictionTHIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of [·], 2013 (this “Agreement”), is entered into by and between Cubist Pharmaceuticals, Inc., a Delaware corporation (“Parent”), and Broadridge Corporate Issuer Solutions, Inc., a Pennsylvania corporation, as Rights Agent.